Drugs Starting with E
BioSniper tracks 111 drugs and molecules whose names begin with E — each linked to its developers, clinical trials, indications, and FDA decisions. Data availability reflects the latest successfully ingested source records; source and as-of dates are shown where available.
Browse A–ZE
- eb1031
- ebglyss1
- eculizumab1
- edoxaban
- eed inhibitor apg-5918
- efavirenz
- efdelikofusp alfa
- efgartigimod alfa
- eflapegrastim1
- eflornithine1
- efocipegtrutide
- eftilagimod alfa
- eftilagimod alpha
- efzofitimod
- egfr inhibitor eras-8011
- egfr/cd3-targeting t-cell engaging molecule tak-186
- eik10011
- eik10051
- ekterly1
- elacestrant1
- eladocagene exuparvovec1
- elagolix1
- elahere1
- elamipretide
- elasomeran
- elebsiran1
- elelyso3
- elenestinib1
- elexacaftor2
- elironrasib1
- elotuzumab1
- elraglusib1
- elranatamab1
- elritercept1
- elsunersen1
- eltrombopag
- eltrombopag olamine2
- eluxadoline1
- elvn-0011
- elvn-0021
- elzonris1
- emaretamig
- emavusertib2
- emicizumab
- empagliflozin1
- empasiprubart
- emraclidine1
- emrosi2
- emtricitabine
- emtricitabine; tenofovir disoproxil
- enalapril
- enasidenib2
- encaleret
- encorafenib1
- enfortumab vedotin
- enobosarm
- enoxaparin
- ensartinib
- ensifentrine4
- entecavir
- entrectinib
- envudeucitinib2
- enzalutamide
- epacadostat
- epcoritamab
- ephedrine2
- epidiferphane
- epidiolex2
- epinephrine
- epirubicin
- eplontersen1
- epoetin alfa
- eptinezumab1
- erdafitinib
- erdafitinib-releasing intravesical system tar-210
- erenumab1
- eribulin2
- erlotinib
- ersodetug1
- erythromycin
- erythromycin lactobionate2
- erzotabart
- escitalopram
- esketamine
- esomeprazole
- esomeprazole magnesium3
- estradiol1
- eszopiclone1
- etakafusp alfa
- etanercept
- etavopivat1
- etelcalcetide
- etentamig
- eteplirsen3
- ethambutol
- ethinyl estradiol
- etigilimab2
- etonogestrel
- etoposide
- etrasimod1
- etrumadenant1
- everolimus1
- evinacumab1
- evolocumab
- evorpacept
- evx-01
- exagamglogene autotemcel1
- exaluren1
- exenatide
- exenatide synthetic
- ezm04141
From drug list to evidence case
Define what these drug programs must prove
Choose the developer, phase, trial, indication, and FDA evidence that should count in your drug thesis.